High-dose pralidoxime for organophosphorus poisoning.
Joshi
Rajnish
R
Department of Medicine, Mahatma Gandhi Institute of Medical Sciences Sevagram, Maharashtra 442102, India; Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA.
Kalantri
S P
SP
Department of Medicine, Mahatma Gandhi Institute of Medical Sciences Sevagram, Maharashtra 442102, India. Electronic address: sp.kalantri@gmail.com.
D001285:Atropine / Q000627:therapeutic use*; D002801:Cholinesterase Reactivators / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D032984:Ethics, Research; D006801:Humans; D009026:Mortality; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D062025:Organophosphate Poisoning; D011220:Pralidoxime Compounds / Q000191:economics / Q000627:therapeutic use*
D002801:Cholinesterase Reactivators; D018727:Muscarinic Antagonists; D011220:Pralidoxime Compounds; D001285:Atropine; C028797:pralidoxime